DrewEdwardBaldwinMD

PubMed

• 160 citations
  Brain and leptomeningeal metastases from cutaneous melanoma: survival outcomes based on clinical features.
  Jeffrey J. Raizer, Wen-Jen Hwu, Katherine S. Panageas, Andrew Wilton, Drew E. Baldwin
  Neuro-Oncology. 2008-04-01
• 13 citations
  Analysis of coronary artery dosimetry in the 3-dimensional era: Implications for organ-at-risk segmentation and dose tolerances in left-sided tangential breast radiation
  Suzanne B. Evans, Babita Panigrahi, Veronika Northrup, Joseph T. Patterson, Drew E. Baldwin
  Practical Radiation Oncology. 2013-04-01
• 9 citations
  Comparison of Drug-Eluting and Bare Metal Stents for Saphenous Vein Graft Lesions (from the National Heart, Lung, and Blood Institute Dynamic Registry)
  Drew E. Baldwin, J. Dawn Abbott, Jeffrey C. Trost, Helen Vlachos, Faith Selzer
  The American Journal of Cardiology. 2010-10-01

Journal Articles

• Analysis of coronary artery dosimetry in the 3-dimensional era: Implications for organ-at-risk segmentation and dose tolerances in left-sided tangential breast radiation.  
  Evans SB, Panigrahi B, Northrup V, Patterson J, Baldwin DE, et al, Practical Radiation Oncology
• May-Thurner syndrome: A not so uncommon cause of a common condition.  
  Peters M, Khazi Syed R, Katz M, Moscona J, Press C, Nijjar V, Bisharat M, Baldwin D, Baylor University Medical Center Proceedings 2012;25(3):231-233

Abstracts/Posters

• A Comparison of Drug-eluting and Bare Metal Stents for Saphenous Vein Graft Lesions: A Report from the NHLBI Dynamic Registry (Abstr).
  Baldwin DE, Trost JC, Abbott JD, et al, Journal of the American College of Cardiology 2008;51 Suppl B:B15

Lectures

• Cardiovascular simulation for medical students. 
  Tulane University School of Medicine
• A comparison of drug-eluting stents and bare metal stents for saphenous vein graft lesions. 
  Oral presentation, ACC-SCAI meeting
• A comparison of drug-eluting stents and bare metal stents for saphenous vein graft lesions. 
  Rhode Island Hospital Research Day
• Saphenous vein graft disease. 
  Tulane Heart and Vascular Institute
• Endovascular approaches to acute DVT. 
  Tulane Heart and Vascular Institute
• Optimal therapy for acute DVT and PE. 
  Tulane University School of Medicine
• Chronic stable angina. 
  New Cardiovascular Horizons conference
• Door-to-balloon time and MI outcomes. 
  New Cardiovascular Horizons conference
• Transradial catheterization and intervention. 
  Tulane Heart and Vascular Institute
• Evidence-based approach to using cholesterol-lowering drugs for prevention of cardiovascular disease. 
  Virginia Mason Medical Center
• Complex femoral artery disease. 
  ev3 Physician Education Summit
• Using cardiac imaging to predict cardiovascular risk. 
  American Council of Life Insurers Annual Meeting
• Assessing response to dual-antiplatelet therapy. 
  Tulane Heart and Vascular Institute
• Evolving Concepts in DVT Therapy. 
  NCVH Fellows’ Course
• What is the evidence for embolic protection in renal artery stenting? 
  New Cardiovascular Horizons conference
• May-Thurner syndrome. 
  New Cardiovascular Horizons conference
• Pathophysiology of cardiovascular disease. 
  Tulane School of Public Health and Tropical Medicine
• Chronic stable angina. 
  New Cardiovascular Horizons conference
• Join now to see all